ProCE Banner Activity

Harnessing Incretins in the Treatment of Diabetes

Clinical Thought
A brief history of the discovery of incretins and how incretin-based therapies revolutionized modern diabetes care.

Released: August 13, 2021

Expiration: August 12, 2022

No longer available for credit.

Share

Faculty

Carol Hatch Wysham

Carol Hatch Wysham, MD

Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Partners

Endocrine Society

ProCE Banner

Faculty Disclosure

Primary Author

Carol Hatch Wysham, MD

Clinical Professor of Medicine
Clinical Endocrinologist
MultiCare/Rockwood Clinic
Spokane, Washington

Carol Hatch Wysham, MD, has disclosed that she has received funds for research support from Abbot, Allergan, Lilly, and Novo Nordisk; consulting fees from Abbott, Janssen, Novo Nordisk, and Sanofi; and fees for non-CME/CE services from AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Sanofi.